Literature DB >> 6946500

Tumor promoters cause a rapid and reversible inhibition of the formation and maintenance of electrical cell coupling in culture.

T Enomoto, Y Sasaki, Y Shiba, Y Kanno, H Yamasaki.   

Abstract

The effect of tumor promoters on electrical coupling between human FL cells was investigated with a microelectrode technique. When a low concentration (100 ng/ml) of 12-O-tetradecanoylphorbol 13-acetate (TPA) was added to culture medium, only 6% of the cells showed electrical coupling after 5 hr, whereas in control medium more than 90% of the cells were coupled. In the presence of TPA, cell coupling remained suppressed for at least another 19 hr. When TPA was washed out from the culture medium, the cells commenced electrical coupling: 90% of the cells were coupled within 4 hr of the removal of TPA, a rate very similar to that of nontreated control cells. Therefore, TPA-mediated inhibition of cell coupling is reversible. When TPA was added to a culture in which more than 90% of the cells had already established electrical coupling, the percentage of coupled cells decreased to 6% within 8 hr, indicating that TPA can also diminish already established cell coupling. Inhibition of cell coupling also was achieved with other mouse skin tumor promoters--phorbol 12,13-didecanoate, ingenol dibenzoate, and mezerein--whereas nonpromoting derivatives--phorbol and 4 alpha-phorbol 12,13-didecanoate-showed no effect. None of these compounds changed the membrane potential, membrane resistance, or growth rate of FL cells. Thus, it appears that TPA and structurally-related tumor promoters specifically disturb the formation or function, or both, of cell-cell junctions, without significantly affecting the general properties of the surface membrane or the growth of FL cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6946500      PMCID: PMC348809          DOI: 10.1073/pnas.78.9.5628

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Tumor initiation and promotion.

Authors:  J D Scribner; R Süss
Journal:  Int Rev Exp Pathol       Date:  1978

2.  The effect of phorbol diesters on chicken embryo fibroblasts.

Authors:  P E Driedger; P M Blumberg
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

Review 3.  Tumor-promoting agents in two-stage carcinogenesis.

Authors:  B L Van Duuren
Journal:  Prog Exp Tumor Res       Date:  1969

4.  Permeability of membrane junctions.

Authors:  W R Loewenstein
Journal:  Ann N Y Acad Sci       Date:  1966-07-14       Impact factor: 5.691

5.  Cell surface membranes in close contact. Role of calcium and magnesium ions.

Authors:  W R Loewenstein
Journal:  J Colloid Interface Sci       Date:  1967-09       Impact factor: 8.128

6.  Calcium-dependent stimulation of BALB/c 3T3 mouse cell DNA synthesis by a tumor-promoting phorbol ester (PMA).

Authors:  A L Boynton; J F Whitfield; R J Isaacs
Journal:  J Cell Physiol       Date:  1976-01       Impact factor: 6.384

7.  Two-stage chemical oncogenesis in cultures of C3H/10T1/2 cells.

Authors:  S Mondal; D W Brankow; C Heidelberger
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

8.  Inhibition of the mixed lymphocyte proliferative response by phorbol esters.

Authors:  A M Mastro; G C Mueller
Journal:  Biochim Biophys Acta       Date:  1978-01-26

9.  Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture.

Authors:  H Yamasaki; E Fibach; U Nudel; I B Weinstein; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  Induction of plasminogen activator in cultured cells by macrocyclic plant diterpene esters and other agents related to tumor promotion.

Authors:  M Wigler; D DeFeo; I B Weinstein
Journal:  Cancer Res       Date:  1978-05       Impact factor: 12.701

View more
  19 in total

1.  Incorporation of the gene for a cell-cell channel protein into transformed cells leads to normalization of growth.

Authors:  P P Mehta; A Hotz-Wagenblatt; B Rose; D Shalloway; W R Loewenstein
Journal:  J Membr Biol       Date:  1991-12       Impact factor: 1.843

2.  PKC phosphorylation disrupts gap junctional communication at G0/S phase in clone 9 cells.

Authors:  S K Koo; D Y Kim; S D Park; K W Kang; C O Joe
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

3.  Differential regulation of gap junctions by proinflammatory mediators in vitro.

Authors:  J Hu; I A Cotgreave
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

4.  Characterization of the progressive sublines derived from a weakly malignant cloned cell line, ER-1, co-inoculated subcutaneously with a foreign body.

Authors:  J Hamada; H Nagayasu; T Kawano; T Mizutani; D Nakata; M Hosokawa; N Takeichi
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

5.  Diacylglycerol downregulates junctional membrane permeability. TMB-8 blocks this effect.

Authors:  T Yada; B Rose; W R Loewenstein
Journal:  J Membr Biol       Date:  1985       Impact factor: 1.843

6.  Characterization of a rat liver epithelial cell line to detect inhibitors of metabolic cooperation.

Authors:  C Jone; J E Trosko; C C Chang
Journal:  In Vitro Cell Dev Biol       Date:  1987-03

7.  Acetylcholine-induced closure of gap junction channels in rat lacrimal glands is probably mediated by protein kinase C.

Authors:  C Randriamampita; C Giaume; J Neyton; A Trautmann
Journal:  Pflugers Arch       Date:  1988-10       Impact factor: 3.657

8.  Cytotoxic, mutagenic, and cell-cell communication inhibitory properties of DDT, lindane, and chlordane on Chinese hamster cells in vitro.

Authors:  G Tsushimoto; C C Chang; J E Trosko; F Matsumura
Journal:  Arch Environ Contam Toxicol       Date:  1983-11       Impact factor: 2.804

9.  Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes.

Authors:  D W Laird; K L Puranam; J P Revel
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

10.  Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells.

Authors:  Gunjan Gakhar; Duy H Hua; Thu Annelise Nguyen
Journal:  Anticancer Drugs       Date:  2010-01       Impact factor: 2.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.